Scientists have developed a new AI model to identify which cancer patients would respond best to a targeted drug on the NHS.
Bevacizumab was approved in December for treating advanced bowel cancer on the NHS.
Scientists have developed a new AI model to identify which cancer patients would respond best to a targeted drug on the NHS.
Bevacizumab was approved in December for treating advanced bowel cancer on the NHS.